Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
RXi Pharmaceuticals Corp
RXII
Healthcare
Biotechnology
"RXi Pharmaceuticals Corp is a clinical-stage RNAi company developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which address significant unmet medical needs."
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:RXII)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(88)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Oct 01, 2018 10:53am
it's a buy today for me
getting onboard this one at these bargain prices,so glta.
(16)
•••
stargazer1
X
View Profile
View Bullboard History
Post by
stargazer1
on Jul 10, 2018 11:36pm
Price shooting upward on high volume
The stock price leveled out the last few days, and today, on a volume of over a million shares it basically went ballistic, going from $1.84 to $2.25. Possibly a press release in the works? Or not
...more
(16)
•••
stargazer1
X
View Profile
View Bullboard History
Post by
stargazer1
on Jul 08, 2017 6:24pm
Possible announcement will send stock shooting upward
RXII’s stock price and warrants started makin unprecedented moves upward Thursday. RXII usually trades a few thousand shares, but Thursday it traded around 200,000 shares, and Friday, over Two
...more
(0)
•••
SimArchitect
X
View Profile
View Bullboard History
Comment by
SimArchitect
on Feb 08, 2017 11:14pm
RE:RXIIW warrant selling at steep steep discount to true market
OMG! I thought I was crazy about those warrants! Thanks for sharing your analysis, I am also 100% bought in!
(0)
•••
RICHGUN
X
View Profile
View Bullboard History
Post by
RICHGUN
on Feb 08, 2017 7:32pm
RXIIW warrant selling at steep steep discount to true market
The-stock is at $.73 and the warrants are trading at .169 Cents. The warrants are good until December 2021 and have a strike price of $.90. If you put them on the CBOE options calculator they come out
...more
(192)
•••
craighenry
X
View Profile
View Bullboard History
Post by
craighenry
on Aug 30, 2015 4:42pm
Could be an interesting week
If we get IND news! Then. SCAR results hopefully in October. I bought in at .39 and .40 last week and week before. Fingers crossed!
(0)
•••
thefabergegg
X
View Profile
View Bullboard History
Post by
thefabergegg
on Jun 10, 2015 6:32pm
just BTFD
getting a lot of institutional buying, LINK CNBC Coverage LINK
(0)
•••
mersoleil11
X
View Profile
View Bullboard History
Post by
mersoleil11
on Jun 09, 2015 10:39am
They do deliver great news too
Tue, Jun 9, 2015, 10:37AM EDT : RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Novel RNAi Platform https://finance.yahoo.com/news/rxi-pharmaceuticals-strengthens
...more
(0)
•••
thefabergegg
X
View Profile
View Bullboard History
Comment by
thefabergegg
on Jun 08, 2015 6:39pm
RE:how come?
they have another 6m to go for delisting if stock is under $1, so stock will likely get run up here.
(26)
•••
campst
X
View Profile
View Bullboard History
Post by
campst
on Jun 08, 2015 12:06pm
how come?
Deficiency of Nasdaq continued listing requirements. No RS prior to PO. What gives?
(0)
•••
thefabergegg
X
View Profile
View Bullboard History
Post by
thefabergegg
on Jun 06, 2015 10:38am
Easy triple
Friend told me about this. Seems harmless here and could easily triple in short term, they need to get stock $1+ or get delisted LOL.
(0)
•••
mersoleil11
X
View Profile
View Bullboard History
Post by
mersoleil11
on Jun 01, 2015 8:26am
Did you know that stock ? take a look, could be $$$$
NEWS today https://www.marketwired.com/press-release/rxi-pharmaceuticals-ceo-dr-geert-cauwenbergh-interviewed-by-the-life-sciences-report-nasdaq-rxii-2024961.htm Extract : "We own our self
...more
(0)
•••
mersoleil11
X
View Profile
View Bullboard History
Post by
mersoleil11
on May 11, 2015 2:53pm
Great news !
Do your DD about RNAI ... I did and I reload this fabulous stock at its year's bottom SP https://www.stockhouse.com/news/press-releases/2015/05/11/rxi-pharmaceuticals-presented-promising-new-data
...more
(0)
•••
mersoleil11
X
View Profile
View Bullboard History
Post by
mersoleil11
on May 06, 2015 8:35am
Price target 5 $
Analysts at HC Wainright lowered their price target on shares of RXi Pharmaceuticals Corp from $9.00 to $5.00 and set a buy rating on the stock in a research note on Tuesday, March 31st. They noted
...more
(26)
•••
campst
X
View Profile
View Bullboard History
Comment by
campst
on Apr 17, 2015 9:16am
RE:Big News!
two analysts covering, one buy, one outperform. Could be a big chart reversal..
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario